Search results
- 1.0381574 - ÚMG 2013 RIV US eng J - Journal Article
Mikyšková, Romana - Indrová, Marie - Polláková, Veronika - Bieblová, Jana - Šímová, Jana - Reiniš, Milan
Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors.
Journal of Immunotherapy. Roč. 35, č. 5 (2012), s. 374-384. ISSN 1524-9557. E-ISSN 1537-4513
R&D Projects: GA ČR(CZ) GPP301/11/P220; GA ČR GA301/09/1024; GA ČR GA301/07/1410
EU Projects: European Commission(XE) 18933 - CLINIGENE
Institutional research plan: CEZ:AV0Z50520514
Institutional support: RVO:68378050
Keywords : myeloid-derived suppressor cells * cyclophosphamide * all-trans-retinoic acid * IL-12 * HPV16
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 3.463, year: 2012
Permanent Link: http://hdl.handle.net/11104/0216407File Download Size Commentary Version Access 0381574.pdf 7 7.1 MB Publisher’s postprint require - 2.0346751 - ÚMG 2011 RIV GR eng J - Journal Article
Bubeník, Jan - Šímová, Jana
Genetically modified cellular vaccines against human papillomavirus type 16 (HPV16)-associated tumors: adjuvant treatment of minimal residual disease after surgery/chemotherapy.
Journal of Balkan Union of Oncology. Roč. 14, č. 1 (2009), s. 169-173. ISSN 1107-0625. E-ISSN 2241-6293
R&D Projects: GA ČR GA301/06/0774; GA ČR GA301/07/1410
EU Projects: European Commission(XE) 18933 - CLINIGENE
Institutional research plan: CEZ:AV0Z50520514
Keywords : residual tumour disease * HPV16 * cellular vaccines
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 0.600, year: 2009
Permanent Link: http://hdl.handle.net/11104/0187687 - 3.0338956 - MBÚ 2010 RIV CZ cze L - Prototype, f. module
Sedláčková, P. - Šimšová, Marcela - Staněk, Ondřej - Šebo, Peter
Purifikovaná králičí polyklonální protilátka proti E7 antigenu HPV16 viru.
[Purified rabbit polyclonal antibody against E7 antigen HPV16 virus.]
Internal code: pAb- E7/HPV16 ; 2009
Technical parameters: Purifikovaná králičí polyklonální protilátka
Economic parameters: Polyklonální králičí protilátka pro imunologická stanovení v ČR a na export
R&D Projects: GA MŠMT 2B06161
Institutional research plan: CEZ:AV0Z50200510
Keywords : Polyclonal antibody E7/HPV16
Subject RIV: EE - Microbiology, Virology
Permanent Link: http://hdl.handle.net/11104/0182601 - 4.0191680 - UMG-J 20033195 RIV GR eng J - Journal Article
Mikyšková, Romana - Indrová, Marie - Šímová, Jana - Jandlová, Táňa - Bieblová, Jana - Jinoch, P. - Bubeník, Jan - Vonka, V.
Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: cytokine and gene therapy with IL-2 and GM-CSF.
International Journal of Oncology. Roč. 24, č. 1 (2004), s. 161-167. ISSN 1019-6439. E-ISSN 1791-2423
R&D Projects: GA MZd NC7148; GA MZd NC7552; GA ČR GA301/01/0985
Institutional research plan: CEZ:AV0Z5052915
Keywords : HPV16 * gene therapy * minimal residual tumour disease
Subject RIV: FD - Oncology ; Hematology
Impact factor: 3.056, year: 2004
Permanent Link: http://hdl.handle.net/11104/0087418 - 5.0191679 - UMG-J 20033194 RIV GR eng J - Journal Article
Bubeník, Jan - Mikyšková, Romana - Reiniš, Milan - Mendoza, Luis - Indrová, Marie - Šmahel, M. - Vonka, V.
Cytokines and dendritic cells as adjuvants for therapy of HPV16-associated tumours.
International Journal of Molecular Medicine. Roč. 12, Supplement 1 (2003), s. S7. ISSN 1107-3756. E-ISSN 1791-244X.
[The 8th World Congress on Advances in Oncology and 6th Internationl Symposium on Molecular Medicine. Hernissos, Crete, 16.10.2003-18.10.2003]
Institutional research plan: CEZ:AV0Z5052915
Keywords : HPV16 * dendritic cells * cytokines
Subject RIV: FD - Oncology ; Hematology
Impact factor: 1.940, year: 2003
Permanent Link: http://hdl.handle.net/11104/0087417 - 6.0191665 - UMG-J 20033176 RIV CZ eng J - Journal Article
Šímová, Jana - Bieblová, Jana - Jandlová, Táňa - Bubeník, Jan
Immunotherapy of HPV-16-associated tumours with tumour cell line/dendritic cell line (TC-1/DC2.4) hybrid vaccines.
Folia Biologica. Roč. 2003, č. 49 (2003), s. 203-206. ISSN 0015-5500. E-ISSN 0015-5500
Institutional research plan: CEZ:AV0Z5052915
Keywords : HPV16 * dendritic cells * fusion
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 0.527, year: 2003
Permanent Link: http://hdl.handle.net/11104/0087403 - 7.0191663 - UMG-J 20033174 RIV CZ eng J - Journal Article
Indrová, Marie - Mikyšková, Romana - Jandlová, Táňa - Vonka, V. - Bubeník, Jan - Bieblová, Jana
Adjuvant cytokine treatment of minimal residual disease after surgical therapy in mice carrying HPV16-associated tumours: Cytolytic activity of spleen cells from tumour regressors.
Folia Biologica. Roč. 2003, č. 49 (2003), s. 217-222. ISSN 0015-5500. E-ISSN 0015-5500
Institutional research plan: CEZ:AV0Z5052915
Keywords : HPV16 * gene therapy * IL-2
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 0.527, year: 2003
Permanent Link: http://hdl.handle.net/11104/0087401 - 8.0191662 - UMG-J 20033173 RIV GR eng J - Journal Article
Indrová, Marie - Bubeník, Jan - Mikyšková, Romana - Vonka, V. - Šmahel, M. - Žák, R. - Šímová, Jana - Bieblová, Jana - Mendoza, Luis - Jandlová, Táňa
Tumour-inhibitory and antimetastatic effects of IL-2 in mice carrying MHC class I- tumours of HPV16 origin.
International Journal of Oncology. Roč. 2002, č. 20 (2002), s. 643-646. ISSN 1019-6439. E-ISSN 1791-2423
Institutional research plan: CEZ:AV0Z5052915
Keywords : HPV16, IL-2 * tumour vaccines * gene therapy
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 2.931, year: 2002
Permanent Link: http://hdl.handle.net/11104/0087400 - 9.0191582 - UMG-J 20033049 RIV GR eng J - Journal Article
Indrová, Marie - Bubeník, Jan - Mikyšková, Romana - Mendoza, Luis - Šímová, Jana - Bieblová, Jana - Jandlová, Táňa - Jinoch, P. - Šmahel, M. - Vonka, V. - Pajtasz-Piasecka, E.
Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
International Journal of Oncology. Roč. 22, č. 3 (2003), s. 691-695. ISSN 1019-6439. E-ISSN 1791-2423
R&D Projects: GA MZd NC7148; GA ČR GA301/00/0114; GA ČR GA301/01/0985; GA AV ČR IAA5052203; GA AV ČR IAA7052002
Grant - others:KBN(PL) P04A12314; Liga proti rakovině(CZ) -
Institutional research plan: CEZ:AV0Z5052915
Keywords : chemotherapy-induced residual tumour disease * immunotherapy * HPV16-associated tumours
Subject RIV: FD - Oncology ; Hematology
Impact factor: 2.536, year: 2003
Permanent Link: http://hdl.handle.net/11104/0087324 - 10.0191581 - UMG-J 20033048 RIV CZ eng J - Journal Article
Mikyšková, Romana - Bieblová, Jana - Šímová, Jana - Indrová, Marie - Jandlová, Táňa - Vonka, V. - Šmahel, M. - Bubeník, Jan - Mendoza, Luis
Local IFN-gamma therapy of HPV16-associated tumours.
Folia Biologica. Roč. 49, č. 1 (2003), s. 26-32. ISSN 0015-5500. E-ISSN 0015-5500
R&D Projects: GA MZd NC7148; GA MZd NC5900; GA ČR GA301/01/0985
Grant - others:GA CZ(CZ) Liga proti rakovině
Institutional research plan: CEZ:AV0Z5052915
Keywords : MHC class I * IFN-gamma * HPV16
Subject RIV: FD - Oncology ; Hematology
Impact factor: 0.527, year: 2003
Permanent Link: http://hdl.handle.net/11104/0087323